Anticoagulants may increase survival rates in coronavirus cases and decrease the need for intubations, according to a study released Wednesday. CDC CHANGES CORONAVIRUS TESTING GUIDANCE; ASYMPTOMATIC PEOPLE NO LONGER REQUIRE TESTSix different blood-thinning treatments were evaluated within the therapeutic group (full dose) and prophylactic (low dose) groups. The study authors found a strong link between blood thinners and reduced risk of in-hospital deaths in the patients receiving the full dose and prophylactic doses of anticoagulants by nearly 50 percent compared to those who did not take blood thinners. Covid-19 patients on full dose and low doses of therapeutic blood thinners also had fewer intubations compared to the non-prescribed blood thinner group, by 31% and 28%, respectively. They concluded that these findings show treatment with blood thinners may be beneficial in COVID-19 patients to prevent blood clots.

Source: Fox News August 26, 2020 22:07 UTC